Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Cash Flow 2017–2020
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow | -264.4M | -207.8M | -153.6M | -118.6M | -58.8M | -35.9M | -41.5M | -32.5M | -25.8M |
| Depreciation & Amort. | 2.6M | 2.5M | 2.3M | 800,000 | 147,000 | 720,000 | 1.3M | 1.3M | 1.2M |
| Investing Activities | |||||||||
| Capital Expenditure | 1.6M | 573,000 | 2.8M | 6.9M | 1.7M | — | 33,000 | 549,000 | 912,000 |
| Free Cash Flow | -266.0M | -208.4M | -156.4M | -125.5M | -60.5M | — | -41.5M | -33.0M | -26.7M |
| Financing Activities | |||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — |
Cogent Biosciences, Inc. Cash Flow — FAQ
Cogent Biosciences, Inc. (COGT) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's cash flow history?
The chart and table above show Cogent Biosciences, Inc.'s cash flow by year and by quarter, including the growth rate.